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ABSTRACT
Background. The body mass index (BMI) in the general
population has increased over the past decades. A high
BMI is a known risk factor for the development of
esophageal adenocarcinoma. Several studies on the inﬂu-
ence of a high BMI on the postoperative course and
survival after esophagectomy have shown contradictory
results. The aim of the present study was to determine the
inﬂuence of a high BMI on postoperative complications
and survival among a large cohort of esophageal cancer
patients.
Methods. Patients who underwent an esophagectomy
between 1993 and 2010 were divided into three groups
according to their BMI: normal weight (\25 kg/m
2),
overweight (25–30 kg/m
2) or obese (C30 kg/m
2). Severity
of complications was scored according to the Dindo clas-
siﬁcation, which was divided into three categories: no
complications, minor to moderate complications, and
severe complications. Long-term survival was determined
according to the Kaplan–Meier method.
Results. A total of 736 esophagectomy patients were
divided into three groups: normal weight (n = 352),
overweight (n = 308), and obese (n = 72). Complications
rates were similar for all groups (65–72%, P = 0.241). The
incidence of anastomotic leakage was higher among obese
patients compared to the other groups (20% vs. 10–12%
respectively, P = 0.019), but there was no signiﬁcant dif-
ference between the three groups regarding the severity of
complications according to the Dindo classiﬁcation
(P = 0.660) or in 5-year survival rates (P = 0.517).
Conclusions. A high BMI is not associated with an
increased incidence or severity of complications after
esophagectomy; however, anastomotic leakage occurred
more frequently in obese patients. Five-year survival rates
were not inﬂuenced by the preoperative BMI. A high BMI
is therefore ought not be an exclusion criterion for
esophagectomy.
In the Western world, together with the incidence of
esophageal adenocarcinoma, the incidence of high body
mass index (BMI) has greatly increased over the past
decades.
1 A high BMI is a known risk factor for the
development of esophageal adenocarcinoma; it is related to
a higher incidence of gastroesophageal reﬂux which is
strongly related to the risk for Barrett esophagus.
2 During
the last few decades, the proportion of overweight esoph-
ageal cancer patients has been rising.
3 Substantial
overweight and obesity are associated with an increased
incidence of cardio respiratory morbidity; therefore, anes-
thesia and surgery can be hazardous in these patients.
4
Moreover, surgery in obese patients can be troublesome,
requiring lengthy surgery and increased blood loss. Con-
sequently, it has been concluded that the rate of
postoperative complications in obese patients is higher.
5
Various studies have evaluated the postoperative out-
come after an esophagectomy in patients with a high BMI
compared to patients of average weight. Several studies
describe no differences in postoperative complications
after an esophagectomy in overweight or obese patients
compared to patients with a BMI of \25 kg/m
2.
6–8 Some
studies, however, report a higher incidence of severe
complications or an increased rate of respiratory and gas-
trointestinal complications in patients with obesity.
9–11 The
severity of complications is unspeciﬁed in these studies,
and because no standardized classiﬁcation of severity of
complications was used, morbidity ranges from urinary
tract infections to postoperative mortality. The large
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the previously mentioned studies difﬁcult.
The inﬂuence of a high BMI on long-term survival has
also been investigated, again with contradictory results.
Some authors describe an improved overall and disease-
free survival rate in obese patients, while others report no
marked differences compared to patients with a normal
BMI.
6,7,9–11
On the basis of the current results, it is not clear whether
a high BMI inﬂuences the postoperative outcome and long-
term survival after an esophagectomy. Therefore, the
relation between a high BMI and the severity of postop-
erative complications was evaluated according to a
validated standard classiﬁcation according to Dindo et al.
12
Furthermore, survival in esophageal carcinoma patients
was evaluated in the present study.
METHODS
Patients
All esophageal cancer patients who underwent surgical
resection at the Academic Medical Centre between January
1993 and December 2010 were included in this study. At
the ﬁrst visit to the outpatient clinic, patient weight and
length were measured, and BMI was calculated according
to the World Health Organization criteria.
13 Patients were
divided into three groups according to their BMI: normal
weight (\25 kg/m
2), overweight (25–30 kg/m
2), or obese
(C30 kg/m
2). There were only 48 patients with a BMI of
\20 kg/m
2 and 15 patients with a BMI of [35 kg/m
2.I t
was not possible to perform a separate statistical analysis
with these small groups.
Patients who underwent neoadjuvant therapy or patients
of whom the preoperative BMI was unknown were
excluded from analyses (Fig. 1). Data, including patient
characteristics, tumor stage, histopathologic features, and
postoperative complications, were collected and entered
into a prospectively monitored database.
Surgery
Surgical resection was performed by conventional open
transthoracic or transhiatal esophagectomy, as previously
described in studies from our center.
14 In brief, transhiatal
esophagectomy was performed with dissection of the
esophagus under direct vision through the widened hiatus
of the diaphragm up to the inferior pulmonary vein. The
tumor and its adjacent lymph nodes were dissected en bloc,
as were the paracardial, lesser curvature, left gastric artery,
celiac trunk, common hepatic artery, and splenic artery
nodes. A 3-cm-wide gastric tube was constructed, and after
left-sided mobilization of the cervical esophagus, the
intrathoracic esophagus was bluntly stripped from the neck
to the upper level of the inferior pulmonary vein with a
large vein stripper.
Transthoracic esophagectomy included a two-ﬁeld
lymphadenectomy. Along with the esophagus, the middle
mediastinal, subcarinal, and right-sided paratracheal lymph
nodes were dissected en bloc. Lymph node dissection
was performed in a manner identical to the transhiatal
approach, as was the construction of the gastric tube.
Pathologic tumor stage was determined according to the
6th edition of the American Joint Committee on Cancer.
15
Deﬁnition of Complications
The severity of postoperative complications was graded
according to the classiﬁcation system composed by Dindo
et al.
12 This system is based on the therapeutic conse-
quences of complications and consists of ﬁve grades. Grade
I complications do not need any medical or surgical
intervention, grade II complications require pharmacolog-
ical treatment, grade III complications need radiological
(IIIa) or surgical (grade IIIb) intervention, and grade IV
complications are life-threatening and represent single-
organ (grade IVa) or multiorgan (grade IVb) dysfunction
(Table 1). Grade V complications are complications lead-
ing to death. Grading of complications was performed
FIG. 1 Flowchart of included esophageal cancer patients who underwent surgical resection between January 1993 and December 2010
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by a panel of four contributing authors (R.B., S.L.,
M.v.B.H., and O.B.). In a previous study performed at our
institute, three categories of complications were deﬁned: no
complications (category 0), minor to moderate complica-
tions (category 1, grade I to IIIb), and severe complications
(category 2, grade IVa, IVb and V).
16 For the purpose of
the present study, the same categories were used.
Statistical Analysis
Statistical calculations were performed by SPSS soft-
ware, version 18.0 (SPSS, Chicago, IL). Differences
between groups were tested by the Mann-Whitney U-test
for continuous data. Differences between three groups were
tested by the Kruskal-Wallis test. The chi-square test or
Fisher’s exact test was performed to compare proportions.
Survival analysis was performed by Kaplan–Meier curves
with log rank tests for signiﬁcance. A two-sided P value of
\0.05 was considered statistically signiﬁcant.
RESULTS
Patient Characteristics
After exclusion of 372 patients who underwent neoad-
juvant therapy or had an unknown BMI, the remaining 736
patients were divided into three groups according to BMI
(Fig. 1).
Patient characteristics are listed in Table 2. Patients with
a normal weight were less likely to have a history of car-
diovascular disease and diabetes mellitus compared to
patients with overweight or obesity (P B 0.001 and
P = 0.021, respectively). Furthermore, adenocarcinomas
were more frequently diagnosed in patients with a BMI of
[25 kg/m
2 (84–88%, P = 0.023).
Surgical Characteristics
Most patients in all three groups underwent transhiatal
esophagectomy (Table 3). The median duration of surgery
was 4.5 h in patients with a normal weight or obesity, and 5
h in overweight patients (P = 0.857). There was no sta-
tistically signiﬁcant difference in perioperative blood loss
(median 1100 ml).
Pathology
A radical resection was achieved in more than 80% of
patients in all BMI classes, and pathologic stage was similar
for all groups regardless of BMI (Table 3). There was no
statistically signiﬁcant difference in the median number of
collected lymph nodes between the different BMI classes
(normalweight,n = 18; overweight, n = 19;obese,n = 19;
P = 0.675),orinthelymphnoderatio(normalweight0.096,
overweight 0.096, and obese 0.076, P = 0.906).
Postoperative Complications
Anastomotic leakage occurred in 20% of patients with
obesity compared to 10% and 12% in patients with normal
weight or overweight (P = 0.019). Chylous leakage was
more frequently present in patients with a BMI of\25 kg/
m
2 (P = 0.030). Overall complications and in-hospital
mortality were comparable for all groups.
When all postoperative complications were categorized
according to the Dindo classiﬁcation, there were no sig-
niﬁcant differences between patients with normal weight,
overweight, or obesity (P = 0.660). In more than 25% of
patients, there were no postoperative complications,
regardless of BMI. The percentage of patients who devel-
oped severe complications varied from 18% to 22% of
patients between the different BMI groups (Table 4).
TABLE 1 Categorization of
the severity of complications in
736 esophageal cancer patients
ICU intensive care unit
According to Dindo et al.
12
Grade Deﬁnition n (%)
– No complications 219 (30)
I Any deviation from the normal postoperative
course without the need for treatment
125 (17)
II Requiring pharmacological treatment with drugs 150 (20)
III Requiring surgical, endoscopic or radiological intervention
IIIa Intervention not under general anesthesia 36 (5)
IIIb Intervention under general anesthesia 63 (9)
IV Life-threatening complication requiring ICU management
IVa Single organ dysfunction 83 (11)
IVb Multiorgan dysfunction 29 (4)
V Death of a patient 31 (4)
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Median survival was 23 months (range, 0–190 months).
Overall 5-year survival was 34.8%, whereas cancer-
speciﬁc 5-year survival was 36.7%. There was no signiﬁ-
cant difference in cancer-speciﬁc 5-year survival between
the different BMI classes (normal weight 36.4%, over-
weight 36.0%, and obesity 39.3%, P = 0.517).
TABLE 2 Patient
characteristics in 736
esophageal cancer patients
divided into three groups
according to BMI
IQR interquartile range, COPD
chronic obstructive pulmonary
disease, ASA American Society
of Anesthesiology
Characteristic BMI\25 kg/m
2,
n (%)
BMI 25–30 kg/m
2,
n (%)
BMI C30 kg/m
2,
n (%)
P-value
No. 352 (48) 308 (42) 76 (10)
Male 256 (75) 255 (83) 58 (76) 0.042
Age, median (IQR) 64 (56–71) 66 (60–73) 63 (56–69) 0.005
Medical history
Cardiovascular 92 (29) 139 (50) 44 (60) \0.001
COPD 45 (13) 31 (10) 6 (8) 0.146
Diabetes mellitus 18 (5) 30 (10) 8 (11) 0.021
ASA 0.337
I 76 (22) 54 (18) 10 (13)
II 192 (55) 198 (64) 46 (61)
III 81 (23) 55 (18) 20 (26)
Preoperative tumor stage 0.208
0 4 (1) 4 (1) 2 (3)
I 30 (10) 33 (13) 8 (11)
II 121 (38) 117 (42) 24 (35)
III 139 (44) 112 (40) 33 (47)
IV 21 (7) 12 (4) 3 (4)
Histology 0.023
Adenocarcinoma 223 (65) 257 (84) 67 (88)
Squamous cell carcinoma 115 (34) 41 (13) 6 (9)
Other 4 (1) 9 (3) 3 (3)
TABLE 3 Histopathologic
characteristics in 736 patients
undergoing esophagectomy
divided into three groups
according to BMI
IQR interquartile range
a Number of positive lymph
nodes divided by total number
of collected lymph nodes
Characteristic BMI\25 kg/m
2
(n = 352)
BMI 25–30 kg/m
2
(n = 308)
BMI C30 kg/m
2
(n = 76)
P-value
Type of resection 0.124
TTE 132 (38) 122 (40) 17 (22)
THE 220 (62) 186 (60) 59 (78)
Duration of surgery,
h, median (IQR)
4.5 (4–6.4) 5 (3.5–6.3) 4.5 (4–6) 0.857
Perioperative blood loss,
ml, median (IQR)
1100 (750–1900) 1200 (700–2000) 1350 (808–2125) 0.265
Radicality of surgery 0.581
R0 294 (85) 261 (86) 61 (81)
R1 50 (15) 42 (14) 14 (19)
Pathologic stage 0.359
0 0 (0) 1 (0.3) 0 (0)
I 38 (11) 48 (16) 10 (14)
II 101 (29) 97 (32) 21 (28)
III 187 (53) 125 (40) 36 (49)
IV 26 (7) 36 (12) 7 (9)
No. of collected lymph
nodes, median (IQR)
18 (11–27) 19 (11–26) 19 (13–24) 0.675
Lymph node ratio, median (IQR)
a 0.096 (0–0.31) 0.096 (0–33) 0.076 (0–0.32) 0.906
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To ensure a homogeneous group, neoadjuvantly treated
patients were excluded. However, because preoperative
therapy is currently the standard treatment for patients with
locoregional esophageal carcinoma, we performed an
analysis on postoperative complications according to the
Dindo classiﬁcation and a survival analysis among these
286 patients.
17,18 Neoadjuvantly treated patients were
subdivided into the same BMI classes as patients who
underwent surgery alone. There were no signiﬁcant dif-
ferences in Dindo classiﬁcation (P = 0.233) or overall
5-year survival (P = 0.962) among the different neoadju-
vantly treated BMI classes.
DISCUSSION
In the present study, the severity of complications
according to the Dindo classiﬁcation and long-term sur-
vival were not statistically different among the individual
BMI classes. Anastomotic leakage occurred more fre-
quently in obese patients but was not associated with a
higher incidence of grade IV and V therapeutic interven-
tions. Subgroup analysis among 286 neoadjuvantly treated
patients showed no statistically signiﬁcant differences in
postoperative outcome or long-term survival among the
different BMI classes.
In a previous study from our center, a BMI of[27 kg/m
2
proved to be an independent risk factor for the development
of anastomotic leakage.
19 A higher rate of anastomotic
leakage among obese esophageal cancer patients has been
reported in previous studies, and this ﬁnding is conﬁrmed by
our results.
9,11 A possible explanation could be the higher
incidence of diabetes mellitus and cardiovascular disease
among obese patients in general, which were also present in
our overweight patient group. Diabetes mellitus is correlated
to impaired wound healing, which can lead to anastomotic
leakage.
20 It has also been speculated that anastomotic
leakage in patients with a high BMI is due to a compromised
vascularity of the conduit because of an increased tension on
the conduit in the thoracic compartment.
9 Furthermore,
performing a cervical anastomosis, which was the standard
in the present series, can be challenging in obese patients.
Previous studies on esophageal cancer patients with a
high BMI have shown contradictory results regarding the
postoperative course, varying from no differences in post-
operative complications to a higher incidence of severe
complications in obese patients.
6,8–11 In accordance with
our results, these studies report that adenocarcinomas occur
more frequently than squamous cell carcinomas in patients
with a high BMI, and that the incidence of diabetes mel-
litus is higher among obese patients.
6,9–11
The severity of complications was reported in only one
other study by Grotenhuis et al.
9 In this series, severe
complications occurred more frequently among patients
with obesity, although the deﬁnition of ‘‘severe’’ was not
clariﬁed. Therefore, it is not possible to compare their
results with the present study.
In contrast to previous studies, we did not ﬁnd any
differences in gastrointestinal or respiratory complications
among the different BMI classes.
10,11 This may be due to a
discrepancy in deﬁnitions, which is why we graded com-
plications according to the Dindo classiﬁcation.
The perception that surgery in obese patients leads to
technical challenges, and therefore lengthy surgery with
increased perioperative blood loss, was not conﬁrmed by
our results; there were no statistically signiﬁcant differ-
ences compared to patients with a normal weight. Equally,
the number of collected lymph nodes among obese patients
was similar to that in patients with a normal weight.
TABLE 4 Impact of BMI on
the postoperative course in 736
patients undergoing
esophagectomy
IQR interquartile range, ICU
intensive care unit
Postoperative course BMI\25 kg/m
2
(n = 352)
BMI 25–30 kg/m
2
(n = 308)
BMI C30 kg/m
2
(n = 76)
P-
value
In-hospital stay, median (IQR) 16 (14–24) 16 (13–25) 16.5 (12–30) 0.421
ICU stay, median (IQR) 2 (1–4) 2 (1–5) 1.5 (1–6) 0.830
Complications, n (%)
Overall 249 (71) 201 (65) 55 (72) 0.241
Anastomotic leakage 34 (10) 38 (12) 15 (20) 0.019
Chylous leakage 20 (6) 12 (4) 0 (0) 0.030
Pulmonary 110 (31) 96 (31) 20 (26) 0.522
Vocal cord paresis 37 (11) 31 (10) 5 (7) 0.391
In-hospital mortality, n (%) 16 (5) 9 (3) 1 (1) 0.117
Complications according to Dindo, n (%) 0.660
Grade 0 100 (28) 99 (32) 20 (26)
Grade I–IIIb 189 (54) 146 (47) 39 (51)
Grade IVa–V 63 (18) 62 (20) 17 (22)
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cant differences in 5-year cancer-speciﬁc survival among
the different BMI classes. This is in accordance with most
other studies on BMI in esophageal cancer patients.
7,9,11
Only two studies reported an improved survival rate in
obese patients.
6,10 In these studies, ﬁndings are explained
by the lower baseline clinical stage in patients with a high
BMI. In the present study, there was no difference in
preoperative clinical stage among the different BMI
classes.
Although this study did not show any differences
amongst the different BMI classes regarding postoperative
complications and long-term survival, we were not able to
evaluate malnourished patients (BMI \25 kg/m
2)o r
severely obese patients (BMI [35 kg/m
2) because the
numbers of these patients were too small. Further research
should be performed focusing on these speciﬁc patient
groups.
In conclusion, a high BMI in esophageal cancer patients
is not associated with an increased incidence of postoper-
ative complications or an impaired long-term survival after
esophagectomy, although anastomotic leakage occurred
more frequently among patients with a BMI of[25 kg/m
2.
Therefore, patients should not be excluded from potentially
curative esophagectomy on the basis of a high BMI alone
but merely judged on comorbidity to choose the optimal
treatment modality.
OPEN ACCESS This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
REFERENCES
1. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends
in obesity among US adults, 1999–2008. JAMA. 2010;303:
235–41.
2. Lundell LR. Etiology and risk factors for esophageal carcinoma.
Dig Dis. 2010;28:641–4.
3. van Heijl M, van Lanschot JJ, Blom RL, et al. [Outcomes of
16 years of oesophageal surgery: low postoperative mortality and
improved long-term survival]. Ned Tijdschr Geneeskd. 2010;154:
A1156.
4. Adams JP, Murphy PG. Obesity in anaesthesia and intensive care.
Br J Anaesth. 2000;85:91–108.
5. Fujitani K, Ajani JA, Crane CH, et al. Impact of induction che-
motherapy and preoperative chemoradiotherapy on operative
morbidity and mortality in patients with locoregional adenocar-
cinoma of the stomach or gastroesophageal junction. Ann Surg
Oncol. 2007;14:2010–7.
6. Melis M, Weber JM, McLoughlin JM, et al. An elevated body
mass index does not reduce survival after esophagectomy for
cancer. Ann Surg Oncol. 2011;18:824–31.
7. MorganMA,LewisWG,HopperAN,etal.Prognosticsigniﬁcance
of body mass indices for patients undergoing esophagectomy for
cancer. Dis Esophagus. 2007;20:29–35.
8. Scipione CN, Chang AC, Pickens A, et al. Transhiatal esopha-
gectomy in the profoundly obese: implications and experience.
Ann Thorac Surg. 2007;84:376–82.
9. Grotenhuis BA, Wijnhoven BP, Hotte GJ, et al. Prognostic value
of body mass index on short-term and long-term outcome after
resection of esophageal cancer. World J Surg. 2010;34:2621–7.
10. Hayashi Y, Correa AM, Hofstetter WL, et al. The inﬂuence of
high body mass index on the prognosis of patients with esopha-
geal cancer after surgery as primary therapy. Cancer. 2010;116:
5619–27.
11. Healy LA, Ryan AM, Gopinath B, et al. Impact of obesity on
outcomes in the management of localized adenocarcinoma of the
esophagus and esophagogastric junction. J Thorac Cardiovasc
Surg. 2007;134:1284–91.
12. Dindo D, Demartines N, Clavien PA. Classiﬁcation of surgical
complications: a new proposal with evaluation in a cohort of
6336 patients and results of a survey. Ann Surg. 2004;240:
205–13.
13. World Health Organization. Obesity: preventing and managing
the global epidemic. Report of a WHO consultation on obesity.
Geneva: World Health Organization; 2000.
14. Hulscher JB, van Sandick JW, de Boer AG, et al. Extended trans-
thoracic resection compared with limited transhiatal resection for
adenocarcinoma of the esophagus. N Engl J Med. 2002;347:
1662–9.
15. Green FL, Page DL, Fleming ID, et al. AJCC cancer staging
handbook. Philadelphia: Lippincott Raven; 2002.
16. Lagarde SM, Reitsma JB, Maris AK, et al. Preoperative predic-
tion of the occurrence and severity of complications after
esophagectomy for cancer with use of a nomogram. Ann Thorac
Surg. 2008;85:1938–45.
17. Gaast AV, van Hagen P, Hulshof MC, et al. Effect of preopera-
tive concurrent chemoradiotherapy on survival of patients with
resectable esophageal or esophagogastric junction cancer: results
from a multicenter randomized phase III study. Presented at the
American Society of Clinical Oncology annual meeting, Chicago,
IL, 2010.
18. Gebski V, Burmeister B, Smithers BM, et al. Survival bene-
ﬁts from neoadjuvant chemoradiotherapy or chemotherapy in
oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8:
226–34.
19. van Heijl M, van Wijngaarden AK, Lagarde SM, et al. Intra-
thoracic manifestations of cervical anastomotic leaks after
transhiatal and transthoracic oesophagectomy. Br J Surg.
2010;97:726–31.
20. Wright CD, Kucharczuk JC, O’Brien SM, et al. Predictors of
major morbidity and mortality after esophagectomy for esopha-
geal cancer: a Society of Thoracic Surgeons General Thoracic
Surgery Database risk adjustment model. J Thorac Cardiovasc
Surg. 2009;137:587–95.
High BMI in Surgery for Esophageal Carcinoma 771